Skip to content

Effects of embedded micro-mindfulness on psychological symptoms in patients with advanced cancer receiving palliative care: a prospective controlled study.

Qin Zhang, Qianer Li, Aiping Deng, Dan Yang, Dan Jia

Frontiers in Oncology August 26, 2026 DOI: 10.3389/fonc.2026.1916107 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Prospective, non-randomized observational study Peer reviewed
Sample size 243
Population Patients with advanced cancer receiving palliative care at West China Hospital
Intervention Micro-mindfulness program
Duration 4 weeks, with weekly assessments
Measures GAD-7, PHQ-9, Distress Thermometer (DT), two-item Insomnia Severity Index (ISI-2), Numeric Rating Scale (NRS)
Topics End-of-life distress Meditation
Keywords Advanced cancer Palliative care Anxiety and depression Psychological symptoms Micro-mindfulness
Key findings Patients who participated in an embedded micro-mindfulness program alongside usual care showed greater reductions over four weeks in anxiety, depressive symptoms, psychological distress, and sleep problems than those receiving usual care alone, while pain intensity did not differ between groups. The authors argue these findings support further evaluation of the brief program as a supportive-care strategy in advanced cancer.

Abstract

Objective: To evaluate changes in psychological distress, anxiety and depressive symptoms, sleep problems, and pain intensity associated with participation in an embedded micro-mindfulness program among patients with advanced cancer receiving palliative care, and to explore factors associated with psychological symptom response.

Methods: This single-center, prospective, non-randomized observational study included 243 patients with advanced cancer receiving palliative care at West China Hospital. Patients who participated in the departmental micro-mindfulness program in addition to usual care comprised the MM group (n = 121), whereas those who received usual care without participating in the program comprised the UC group (n = 122). Outcomes were assessed at baseline and weekly for 4 weeks. Primary outcomes were anxiety and depressive symptoms assessed using the GAD-7 and PHQ-9, respectively. Secondary outcomes included psychological distress assessed using the Distress Thermometer (DT), sleep problems assessed using the two-item Insomnia Severity Index (ISI-2), and pain intensity assessed using the Numeric Rating Scale (NRS).

Results: Baseline characteristics were comparable between groups. Significant group × time interactions were observed for GAD-7 (P = 0.001), PHQ-9 (P = 0.002), DT (P < 0.001), and ISI-2 (P < 0.001), with greater reductions over time observed in the MM group. The group × time interaction for NRS was not significant (P = 0.371). In the MM group, 73 patients (60.3%) achieved psychological symptom response.

Conclusion: Embedded micro-mindfulness was associated with greater improvements in anxiety, depressive symptoms, psychological distress, and sleep problems, but not pain intensity. These findings support further evaluation of this brief program as a supportive-care strategy for patients with advanced cancer receiving palliative care.

Comparable studies

Other non-randomized and open-label trials on end-of-life distress, most cited first.

Study Year Design Participants
A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study) Patients with advanced cancer and moderate to severe major depressive disorder 2023 Single-arm, open-label phase II trial n = 20
Mindfulness and compassion training on daily work with patients and within the multiprofessional palliative care team: a retrospective self-assessment study Employees of a university-based specialized palliative care unit 2023 Observational cohort (pre-post self-assessment) n = 24
Intranasal Ketamine for Existential Distress in Advanced Cancer. Patients with advanced cancer receiving palliative care 2026 Secondary analysis of a clinical trial n = 15
PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial Adults with advanced, incurable illness and estimated prognosis of 1–12 months,... 2026 Open label, single-arm clinical trial n = 20
Effect of mindfulness-based stress reduction on nursing interns' death anxiety, stress, and palliative care self-efficacy during oncology end-of-life training. Final-year Bachelor of Science in nursing interns at Prince Sattam Bin Abdulaziz... 2026 Quasi-experimental pre-post study n = 120

Citations in the library

Explore topics